TBPH Stockholders Equity
Theravance Biopharma Inc · Stockholders Equity
TBPH Stockholders Equity
Latest reported$296.72Mperiod ending
TBPH FY Shareholders Equity (-$140.72M → $296.72M)
Annual shareholders equity
High-resolution chart · PNG
TBPH stockholders equity history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stockholders Equity (USD) |
|---|---|
| 296,723,000 | |
| 175,545,000 | |
| 212,995,000 | |
| 441,800,000 | |
| -338,573,000 | |
| -303,751,000 | |
| -223,840,000 | |
| -51,589,000 | |
| 115,178,000 | |
| 350,231,000 | |
| 243,065,000 | |
| 289,787,000 | |
| -17,035,000 | |
| -6,990,000 | |
| -140,724,000 |